Linfoma/Leucemia de células T del adulto y criptococosis sistémica: Reporte de dos casos en un hospital peruano

Autores/as

DOI:

https://doi.org/10.24265/horizmed.2019.v19n1.14

Palabras clave:

dengue, estrategias, epidemiología

Resumen

El linfoma/leucemia de células T adulto (LLCTA) es una neoplasia linfoide causada por la infección por el virus linfotrópico humano tipo 1, retrovirus endémico en nuestro país. Una patología heterogénea en su presentación, con variedades de pobre pronóstico, empeorado aún más con la mayor frecuencia de infecciones oportunistas. Se presentan dos casos de pacientes con variedades agresivas de la enfermedad complicadas con una criptococosis sistémica. Reforzamos la necesidad de un enfoque diagnóstico completo y un monitoreo continuo del paciente con LLCTA.

Descargas

Los datos de descargas todavía no están disponibles.

Citas

1. Proietti FA, Carneiro-Proietti AB, Catalan-Soares BC, Murphy EL. Global epidemiology of HTLV-I infection and associated diseases. Oncogene. 2005; 24(39): 6058–68.

2. Utsunomiya A, Choi I, Chihara D, Seto M. Recent advances in the treatment of adult T-cell leukemia-lymphomas. Cancer Sci. 2015; 106: 344-351.

3. Chihara D, Ito H, Matsuda T, Katanoda K, Shibata A, Taniguchi S et al. Association between decreasing trend in the mortality of adult T-cell leukemia ⁄ lymphoma and allogeneic hematopoietic stem cell transplants in Japan: analysis of Japanese vital statistics and Japan Society for Hematopoietic Cell Transplantation (JSHCT). Blood Cancer J. 2013; 3(11): e159.

4. Tsukasaki K, Tobinai K. Human T-cell lymphotropic virus type I-associated adult T-cell leukemia-lymphoma: new directions in clinical research. Clin Cancer Res. 2014;20(20):5217-25.

5. Shimoyama M. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984–87). Br J Haematol 1991; 79: 428–37.

6. Bazarbachi A, Suarez F, Fields P, Hermine O. How I treat adult T-cell leukemia/lymphoma. Blood. 2011; 118 (7): 1736-45.

7. Katsuya H, Ishitsuka K. Treatment advances and prognosis for patients with adult T-cell leukemia-lymphoma. J Clin Exp Hematop. 2017;57(3):87-97.

8. Maeda T, Babazono A, Nishi T, Yasui M, Matsuda S, Fushimi k, et al. The Impact of Opportunistic Infections on Clinical Outcome and Healthcare Resource Uses for Adult T Cell Leukaemia. Plos One. 2015; 10(8): 2-12.

9. Dioverti M, Parikh S, Osmon D, Habermann T, Tande A. Cryptococcus neoformans infections in patients with lymphoproliferative neoplasms. Leuk Lymphoma. 2018,6:1-7.

10. Maeda T, Babazono A, Nishi T, Yasui M, Matsuda S, Fushimi K, et al. The Impact of Opportunistic Infections on Clinical Outcome and Healthcare Resource Uses for Adult T Cell Leukaemia. PLoS ONE. 2015;10(8): e0135042.

11. Chalkias S, Doweiko J, Eliopoulos G. An enabling act. Open Forum Infect Dis. 2014; 1(1): ofu008.

12. Marsh BJ. Infectious complications of human T cell leukemia/ lymphoma virus type I infection. Clin Infect Dis. 1996;23(1):138-45.

13. Tashiro T, Yamasaki T, Nagai H, Kikuchi H, Nasu M. Immunological studies on opportunistic infection and the development of adult T-cell leukemia. Intern Med 1992;31:1132-36.

14. Rhew DC, Gaultier CR, Daar ES, Zakowski PC, Said J. Infections in patients with chronic adult T-cell leukemia/lymphoma: Case report and review. Clin Infect Dis. 1995;21(4):1014-6.

15. Takasaki Y, Iwanaga M, Imaizumi Y, Tawara M, Joh T, Kohno T et al. Long-term study of indolent adult T-cell leukemia-lymphoma. Blood. 2010;115(22):4337-43.

16. Malpica L, Pimentel A, Reis I, Gotuzzo E, Lekakis L, Komanduri K. Epidemiology, clinical features, and outcome of HTLV-1-related ATLL in an area of prevalence in the United States. Blood Adv. 2018;2(6), 607-20.

17. Miyoshi I, Hatakeyama N, Daibata M, Taguchi H. Cutaneous and nodal cryptococcosis in an ATL Patient. Intern Med. 2006;45(19):1105-06.

18. Yamada W, Yamada H, Murata K, Kosugi H, Asano Y, Mochizuki K, Ishida K. Case of cryptococcal choroiditis in adult with T-cell leukemia/lymphoma. J Infect Chemother. 2018; S1341- 321X(18)30190-9.

19. Suzuki T, Ichiki Y, Kamihira T, Akamine M, Iida M, Ogawa K, Fujisawa K. A case of hepatic cryptococcosis complicated by adult T-cell leukemia. Nihon Shokakibyo Gakkai Zasshi. 112(12):2168-75.

20. Tanaka T, Sekioka T, Usui M, Imashuku S. Opportunistic Infections in Patients with HTLV-1 Infection. Case Rep Hematol. 2015:943867. .

21. Concha-Velasco F, González-Lagos E, Seas C, Bustamante B. Factors associated with early mycological clearance in HIV-associated cryptococcal meningitis. PLoS One. 2017;12(3): e0174459.

22. Henao-Martínez AF, Chastain DB, Franco-Paredes C. Treatment of cryptococcosis in non-HIV immunocompromised patients. Curr Opin Infect Dis. 2018;31(4):278-85.

23. Bongomin F, Oladele RO, Gago S, Moore CB, Richardson MD. A systematic review of fluconazole resistance in clinical isolates of Cryptococcus species. Mycoses. 2018;61(5):290-97.

24. NCCN Guidelines [Internet]. Clinical Practice Guideliness in Oncology.T cell-Lyphomas.Version.2019.[citado 1 de agosto de 2018]. Disponible en: https://www.nccn.org/professionals/physician_gls/pdf/t-cell.pdf

##submission.downloads##

Publicado

2019-03-31

Cómo citar

Altamirano-Molina, M. A., Pérez-Lazo, G., Alvarez Barcena, A., Delgado Gonzáles, V., & Zapata, R. E. (2019). Linfoma/Leucemia de células T del adulto y criptococosis sistémica: Reporte de dos casos en un hospital peruano. Horizonte Médico (Lima), 19(1), 87–92. https://doi.org/10.24265/horizmed.2019.v19n1.14

Número

Sección

Caso clínico

Artículos más leídos del mismo autor/a